Form 4: Calix Director Kathleen M. Crusco Reports Stock Option Grant

Director Kathleen M. Crusco reports the acquisition of stock options for Calix, Inc.

Summary

• Kathleen M. Crusco, a director of Calix, Inc., filed a Form 4 with the SEC.
• The filing reports the grant of stock options to Crusco on May 9, 2024.
• The stock options give Crusco the right to buy 12,262 shares of Calix common stock at an exercise price of $30.07 per share.
• The options vest on the earlier of May 9, 2025, or the day before the next annual meeting of stockholders.
• The options expire on May 9, 2034.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing regarding stock option grants, indicating a neutral sentiment.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment.

Industry Context

Stock option grants are a common form of executive compensation in the technology industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in the technology sector.
• Companies like Cisco, Juniper Networks, and Arista Networks also utilize stock options as part of their executive compensation plans.
• The vesting schedules and exercise prices are typically structured to incentivize long-term performance and align with shareholder interests.

Stakeholder Impact

• The stock option grant could potentially dilute existing shareholders if the options are exercised.
• The grant incentivizes the director to work towards increasing shareholder value.

Key Dates